We also found that a proportion of CD90-labeled cells of IPF patients expressed myofibroblast marker α-SMA (Fig. 1C) and aggregated in fibroblastic foci, which suggested that LR-MSC was the origin of the myofibroblast during fibrotic lung disease. Here, THY1 is linked to idiopathic pulmonary fibrosis.